J. David Hansen
2014
In 2014, J. David Hansen earned a total compensation of $373.1K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $32,318 |
|---|---|
| Salary | $315,660 |
| Other | $25,142 |
| Total | $373,120 |
Hansen received $315.7K in salary, accounting for 85% of the total pay in 2014.
Hansen also received $32.3K in bonus and $25.1K in other compensation.
Rankings
In 2014, J. David Hansen's compensation ranked 11,179th out of 13,032 executives tracked by ExecPay. In other words, Hansen earned more than 14.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,179 out of 13,032 | 14th |
Division Manufacturing | 4,281 out of 4,966 | 14th |
Major group Chemicals And Allied Products | 1,476 out of 1,686 | 13th |
Industry group Drugs | 1,190 out of 1,365 | 13th |
Industry Pharmaceutical Preparations | 916 out of 1,043 | 12th |
Source: SEC filing on May 27, 2016.
Hansen's colleagues
We found four more compensation records of executives who worked with J. David Hansen at MabVax Therapeutics Holdings in 2014.
2014
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2014
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
2014
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
2014
Paul Maffuid
MabVax Therapeutics Holdings